Kakkar VV - Search Results

1

Pre-thrombotic state and impaired fibrinolytic potential in coronary heart disease patients with left ventricular dysfunction.

De Lorenzo F, Xiao H, Scully M, Kadziola Z, Kakkar VV. De Lorenzo F, et al. Among authors: kakkar vv. Blood Coagul Fibrinolysis. 2003 Jan;14(1):67-75. doi: 10.1097/00001721-200301000-00012. Blood Coagul Fibrinolysis. 2003. PMID: 12544731

2

Association of overall adiposity rather than body mass index with lipids and procoagulant factors.

De Lorenzo F, Mukherjee M, Kadziola Z, Suleiman S, Kakkar VV. De Lorenzo F, et al. Among authors: kakkar vv. Thromb Haemost. 1998 Oct;80(4):603-6. Thromb Haemost. 1998. PMID: 9798978

3

Haemostatic factors and risk of coronary heart disease.

De Lorenzo F, Kadziola Z, Kakkar VV. De Lorenzo F, et al. Among authors: kakkar vv. Blood Coagul Fibrinolysis. 1999 Mar;10(2):113-4. doi: 10.1097/00001721-199903000-00010. Blood Coagul Fibrinolysis. 1999. PMID: 10192662 No abstract available.

4

Induced ischemia detected by dobutamine stress echocardiography in coronary heart disease patients after myocardial re-vascularization. Experience in a District General Hospital.

De Lorenzo F, Saba N, Dancy M, Kakkar VV, Kadziola Z, Xiao HB. De Lorenzo F, et al. Among authors: kakkar vv. Int J Cardiol. 2002 May;83(2):119-24. doi: 10.1016/s0167-5273(02)00029-3. Int J Cardiol. 2002. PMID: 12007683

5

Influence of intrinsic and extrinsic plasminogen upon the lysis of thrombi in vitro.

Nishino N, Kakkar VV, Scully MF. Nishino N, et al. Among authors: kakkar vv. Thromb Haemost. 1991 Dec 2;66(6):672-7. Thromb Haemost. 1991. PMID: 1796413

6

Properties of thrombolytic agents in vitro using a perfusion circuit attaining shear stress at physiological levels.

Nishino N, Scully MF, Rampling MW, Kakkar VV. Nishino N, et al. Among authors: kakkar vv. Thromb Haemost. 1990 Dec 28;64(4):550-5. Thromb Haemost. 1990. PMID: 2128138

7

Potentiation by Lys-plasminogen of clot lysis by single or two chain urokinase-type plasminogen activator or tissue-type plasminogen activator.

Watahiki Y, Scully MF, Ellis V, Kakkar VV. Watahiki Y, et al. Among authors: kakkar vv. Thromb Haemost. 1989 Jun 30;61(3):502-6. Thromb Haemost. 1989. PMID: 2508259

8

Intermittent plasminogen-streptokinase treatment of deep vein thrombosis.

Kakkar VV, Scully MF. Kakkar VV, et al. Haemostasis. 1988;18 Suppl 1:127-38. doi: 10.1159/000215848. Haemostasis. 1988. PMID: 3350394

9

Inhibition of fibrinolytic activity by hyaluronan and its alcohol ester derivatives.

Scully MF, Kakkar VV, Goodwin CA, O'Regan M. Scully MF, et al. Among authors: kakkar vv. Thromb Res. 1995 May 1;78(3):255-8. doi: 10.1016/0049-3848(95)90876-h. Thromb Res. 1995. PMID: 7631306 No abstract available.

10

Annexin V as a probe of the contribution of anionic phospholipids to the procoagulant activity of tumour cell surfaces.

Sugimura M, Donato R, Kakkar VV, Scully MF. Sugimura M, et al. Among authors: kakkar vv. Blood Coagul Fibrinolysis. 1994 Jun;5(3):365-73. Blood Coagul Fibrinolysis. 1994. PMID: 8075308

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

569 results

Search Page

Filters